BCK Capital Management’s Tourmaline Bio TRML Stock Holding History

BCK Capital Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,471	Closed	-$931K	–	50
2025 Q3	$931K	Buy	+19,471	New	+$540K	0.99%	42

BCK Capital Management's TRML Position: Q4 2025 in Review

BCK Capital Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 19,471 shares — an estimated $931K sold.

BCK Capital Management first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $931K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

BCK Capital Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
BCK Capital Management sold 19,471 Tourmaline Bio shares in Q4 2025, an estimated $931K.
BCK Capital Management first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
BCK Capital Management's Tourmaline Bio position peaked at $931K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on BCK Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.